Session » 5T091 ACR Abstract: Spondyloarthritis Incl PsA–Clinical IV: Comorbid/Related Conditions(2826–2831)

Date: Tuesday, October 23, 2018

Time: 2:30PM-4:00PM

Meeting: 2018 ACR/ARHP Annual Meeting

2:30PM-4:00PM: Abstract Number: 2826

Emergence of Severe Spondyloarthropathy Related Entheseal Pathology Following Successful Vedolizumab Therapy for Inflammatory Bowel Disease

2:30PM-4:00PM: Abstract Number: 2831

High Need for Anti-TNF Therapy after Withdrawal Strategy in Early Peripheral Spondyloarthritis

2:30PM-4:00PM: Abstract Number: 2827

Remission Targets and Prevention of Subclinical Atherosclerosis in Psoriatic Arthritis- Which Target Should We Choose?

2:30PM-4:00PM: Abstract Number: 2830

Synovitis in Psoriatic Arthritis and Seronegative Rheumatoid Arthritis: Differential Histological Features

2:30PM-4:00PM: Abstract Number: 2829

The Response to TNF-Blockers Treatment of Spa Patients Is Influenced By the Interplay between HLA-B27 and Gut Microbiota Composition at Baseline

2:30PM-4:00PM: Abstract Number: 2828

Utility of Fecal Calprotectin Levels for the Diagnosis of Inflammatory Bowel Disease in Patients with Spondylorarthritis

« View all sessions from this meeting